MedPath

The Case Comprehensive Cancer Center

The Case Comprehensive Cancer Center logo
🇺🇸United States
Ownership
Subsidiary
Established
1826-01-01
Employees
5K
Market Cap
-
Website
http://www.case.edu/cancer

Adjuvant Stage 2-3A Breast Cancer With Positive Lymph Nodes

Phase 2
Completed
Conditions
Breast Cancer
Interventions
Biological: filgrastim
Procedure: adjuvant therapy
Radiation: radiation therapy
First Posted Date
2003-01-27
Last Posted Date
2012-10-02
Lead Sponsor
Case Comprehensive Cancer Center
Target Recruit Count
16
Registration Number
NCT00007904
Locations
🇺🇸

Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

🇺🇸

UH-LUICC, Mentor, Ohio, United States

🇺🇸

UH-Chagrin Highlands, Orange Village, Ohio, United States

Non-Ablative Allo HSCT For Hematologic Malignancies or SAA

Phase 2
Completed
Conditions
Chronic Myeloproliferative Disorders
Leukemia
Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
Myelodysplastic Syndromes
Myelodysplastic/Myeloproliferative Diseases
Precancerous/Nonmalignant Condition
Small Intestine Cancer
First Posted Date
2003-01-27
Last Posted Date
2011-12-08
Lead Sponsor
Case Comprehensive Cancer Center
Target Recruit Count
58
Registration Number
NCT00006379
Locations
🇺🇸

Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer

Phase 2
Completed
Conditions
Colorectal Cancer
First Posted Date
2003-01-27
Last Posted Date
2010-06-10
Lead Sponsor
Case Comprehensive Cancer Center
Target Recruit Count
13
Registration Number
NCT00005981
Locations
🇺🇸

Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Gemcitabine Plus Cisplatin in Treating Patients With Metastatic Kidney Cancer

Phase 2
Completed
Conditions
Kidney Cancer
First Posted Date
2003-01-27
Last Posted Date
2010-06-11
Lead Sponsor
Case Comprehensive Cancer Center
Target Recruit Count
32
Registration Number
NCT00003928
Locations
🇺🇸

Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

Rebeccamycin Analogue in Treating Patients With Advanced Liver and/or Biliary Cancer

Phase 2
Terminated
Conditions
Extrahepatic Bile Duct Cancer
Gallbladder Cancer
Liver Cancer
First Posted Date
2003-01-27
Last Posted Date
2010-06-11
Lead Sponsor
Case Comprehensive Cancer Center
Target Recruit Count
72
Registration Number
NCT00005997
Locations
🇺🇸

Comprehensive Cancer Center at University of Alabama at Birmingham, Birmingham, Alabama, United States

🇺🇸

Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

🇺🇸

Hillman Cancer Center at University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States

Paclitaxel Plus Radiation Therapy in Treating Women With Stage II or Stage III Breast Cancer

Phase 2
Completed
Conditions
Breast Cancer
First Posted Date
2003-01-27
Last Posted Date
2023-11-30
Lead Sponsor
Case Comprehensive Cancer Center
Target Recruit Count
44
Registration Number
NCT00006256
Locations
🇺🇸

University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

🇺🇸

UH-Geauga, Chardon, Ohio, United States

🇺🇸

UH-Monarch, Mayfield Heights, Ohio, United States

and more 6 locations
© Copyright 2025. All Rights Reserved by MedPath